Paques Biomaterials Secures €14m in Funding

Paques Biomaterials, concluded a new funding round, securing €14 million to advance the production of a biopolymer that offers the benefits of plastic without its associated drawbacks. Notable investors, including impact investor Invest-NL and the NOM, contributed to this successful funding round. The raised capital will facilitate scaling up operations through the establishment of a Caleyda Extraction Facility in Emmen. This facility aims to extract raw PHA, transforming it into Paques' biopolymer branded as Caleyda®.